Patents Assigned to Dey, L.P.
-
Patent number: 8084461Abstract: The present invention relates to a dual bronchodilator inhalation solution, system, kit and method for relieving bronchospasm in patients suffering from chronic obstructive pulmonary disease (COPD). In one alternative embodiment, the solution of the present invention is a prepackaged, sterile, premixed, premeasured single unit dose of albuterol and ipratropium bromide for patients suffering from COPD. The present solution may be free of antimicrobial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 2.50 mg albuterol and about 0.50 mg ipratropium bromide in a 0.5 ml volume.Type: GrantFiled: January 18, 2005Date of Patent: December 27, 2011Assignee: Dey, L.P.Inventors: Imtiaz Chaudry, Partha Banerjee
-
Publication number: 20110166202Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof, and a steroidal anti-inflammatory agent. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: ApplicationFiled: March 21, 2011Publication date: July 7, 2011Applicant: DEY, L.P.Inventors: Partha S. Banerjee, Imtiaz A. Chaudry, Stephen Pham
-
Patent number: 7811606Abstract: Nasal pharmaceutical formulations comprising a drug substance having a specific particle size distribution profile are disclosed herein. Such profile provides increased bioavailability, increased efficacy or prolonged therapeutic effect of the drug substance when administered intranasally. The formulations of the present invention may comprise one or more corticosteroids having a specific particle size distribution profile. In a preferred embodiment, the corticosteroid is beclomethasone or a pharmaceutically acceptable derivative thereof for the treatment of one or more symptoms of rhinitis. Preferably, the drug substance is beclomethasone dipropionate. The formulations herein may be provided as an aqueous suspension suitable for inhalation via the intranasal route.Type: GrantFiled: April 16, 2003Date of Patent: October 12, 2010Assignee: Dey, L.P.Inventor: Imtiaz Chaudry
-
Publication number: 20100240761Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: ApplicationFiled: May 24, 2010Publication date: September 23, 2010Applicant: DEY, L.P.Inventors: Partha S. Banerjee, Imtiaz A. Chaudry, Stephen Pham
-
Publication number: 20100143375Abstract: Compositions and methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders are provided. The compositions provided herein are nebulizable compositions comprising quaternary ammonium muscarinic receptor antagonists. The compositions are suitable for direct administration to a patient in need thereof via a nebulizer. Also provided are kits which comprise of the nebulizable composition of the invention in combination with a nebulizer. Also provided is a method of treating, preventing, or amelioration of one or more symptoms of bronchoconstrictive disorders by administering a therapeutically effective amount of the nebulizable composition of the invention via the use of a nebulizer to a patient in need thereof with minimal to no exposure of the nebulizable composition to the body surface of the patient.Type: ApplicationFiled: February 12, 2010Publication date: June 10, 2010Applicant: DEY, L.P.Inventor: Imtiaz A. Chaudry
-
Publication number: 20100120734Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof, and a steroidal anti-inflammatory agent. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: ApplicationFiled: January 22, 2010Publication date: May 13, 2010Applicant: DEY, L.P.Inventors: Partha S. Banerjee, Imtiaz A. Chaudry, Stephen Pham
-
Publication number: 20100069342Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof, and a steroidal anti-inflammatory agent. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: ApplicationFiled: November 24, 2009Publication date: March 18, 2010Applicant: DEY, L.P.Inventors: Partha S. Banerjee, Imtiaz A. Chaudry, Stephen Pham
-
Publication number: 20090143475Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: ApplicationFiled: December 19, 2008Publication date: June 4, 2009Applicant: DEY, L.P.Inventors: Partha S. Banerjee, Imtiaz A. Chaudry, Stephen Pham
-
Patent number: 7348362Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: GrantFiled: July 9, 2004Date of Patent: March 25, 2008Assignee: Dey, L.P.Inventors: Partha S. Banerjee, Imtiaz A. Chaudry, Stephen Pham
-
Publication number: 20070274925Abstract: Compositions and methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders are provided. The compositions provided herein are nebulizable compositions comprising quaternary ammonium muscarinic receptor antagonists. The compositions are suitable for direct administration to a patient in need thereof via a nebulizer. Also provided are kits which comprise of the nebulizable composition of the invention in combination with a nebulizer. Also provided is a method of treating, preventing, or amelioration of one or more symptoms of bronchoconstrictive disorders by administering a therapeutically effective amount of the nebulizable composition of the invention via the use of a nebulizer to a patient in need thereof with minimal to no exposure of the nebulizable composition to the body surface of the patient.Type: ApplicationFiled: May 25, 2007Publication date: November 29, 2007Applicant: DEY, L.P.Inventor: Imtiaz A. Chaudry
-
Publication number: 20070166236Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: ApplicationFiled: March 20, 2007Publication date: July 19, 2007Applicant: DEY, L.P.Inventors: Partha Banerjee, Imtiaz Chaudry, Stephen Pham
-
Publication number: 20070166240Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: ApplicationFiled: March 20, 2007Publication date: July 19, 2007Applicant: DEY, L.P.Inventors: Partha Banerjee, Imtiaz Chaudry, Stephen Pham
-
Publication number: 20070166235Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: ApplicationFiled: March 20, 2007Publication date: July 19, 2007Applicant: DEY, L.P.Inventors: Partha Banerjee, Imtiaz Chaudry, Stephen Pham
-
Publication number: 20070160541Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: ApplicationFiled: March 20, 2007Publication date: July 12, 2007Applicant: DEY, L.P.Inventors: Imtiaz Chaudry, Stephen Pham, Partha Banerjee
-
Patent number: 6814953Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: GrantFiled: May 3, 2002Date of Patent: November 9, 2004Assignee: Dey L.P.Inventors: Partha S. Banerjee, Stephen Pham, Samuel O. Akapo, Imtiaz A. Chaudry
-
Publication number: 20040109826Abstract: Stabilized albuterol compositions are provided. The compositions are aqueous inhalation compositions containing albuterol; a buffer, such as citric acid; and a metal chelator, such as EDTA.Type: ApplicationFiled: February 4, 2003Publication date: June 10, 2004Applicant: Dey, L.P.Inventors: Ramana Malladi, Partha S. Banerjee, Satyajit V. Erram
-
Patent number: 6702997Abstract: The present invention relates to an albuterol inhalation solution, system, kit and method for relieving bronchospasm in children suffering from asthma. In one alternative embodiment, the solution of the present invention is a sterile, premixed, premeasured single unit dose of albuterol for asthmatic patients 2 to 12 years of age. The present solution may be free of anti-microbial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 0.63 mg or about 1.25 mg albuterol.Type: GrantFiled: December 28, 2001Date of Patent: March 9, 2004Assignee: Dey, L.P.Inventors: Imtiaz Chaudry, Partha Banerjee
-
Publication number: 20040023935Abstract: Bronchodilating concentrates and diluted compositions, methods of use thereof, and processes for making the concentrates and diluted compositions, are provided. The compositions are intended for administration as a nebulized aerosol. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: ApplicationFiled: August 2, 2002Publication date: February 5, 2004Applicant: Dey, L.P.Inventors: Partha S. Banerjee, Ramana R. Malladi, Imtiaz A. Chaudry
-
Patent number: 6667344Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.Type: GrantFiled: June 22, 2001Date of Patent: December 23, 2003Assignee: Dey, L.P.Inventors: Partha S. Banerjee, Stephen Pham, Samuel O. Akapo, Imtiaz A. Chaudry
-
Patent number: 6632842Abstract: The present invention relates to a dual bronchodilator inhalation solution, system, kit and method for relieving bronchospasm in patients suffering from chronic obstructive pulmonary disease (COPD). In one alternative embodiment, the solution of the present invention is a prepackaged, sterile, premixed, premeasured single unit dose of albuterol and ipratropium bromide for patients suffering from COPD. The present solution may be free of antimicrobial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 2.50 mg albuterol and about 0.50 mg ipratropium bromide.Type: GrantFiled: June 3, 2002Date of Patent: October 14, 2003Assignee: Dey, L.P.Inventors: Imtiaz Chaudry, Partha Banerjee